The landscape of managing diabetes is evolving with the introduction of skin-applied GLP-1 therapy. These novel patches offer a likely simpler alternative to needle administrations for individuals dealing with diabetes mellitus type 2 . These patches deliver glucagon-like peptide-1 directly throu